WORLD HEALTH ORGANIZATION
SEVENTIETH WORLD HEALTH ASSEMBLY
GENEVA, 22–31 MAY 2017
RESOLUTIONS AND DECISIONS ANNEXES
GENEVA
2017
- ii -
ABBREVIATIONS
Abbreviations used in WHO documentation include the following:
ASEAN – Association of Southeast Asian Nations
FAO – Food and Agriculture Organization of the United Nations
IAEA – International Atomic Energy Agency
IARC – International Agency for Research on Cancer
ICAO – International Civil Aviation Organization
IFAD – International Fund for Agricultural Development
ILO – International Labour Organization (Office)
IMF – International Monetary Fund IMO – International Maritime
Organization
INCB – International Narcotics Control Board
IOM – International Organization for Migration
ITU – International Telecommunication Union
OECD – Organisation for Economic Co-operation and Development OIE – World Organisation for Animal
Health
PAHO – Pan American Health Organization
UNAIDS – Joint United Nations Programme on HIV/AIDS
UNCTAD – United Nations Conference on Trade and Development UNDP – United Nations Development
Programme
UNEP – United Nations Environment Programme
UNESCO – United Nations Educational, Scientific and Cultural Organization
UNFPA – United Nations Population Fund UNHCR – Office of the United Nations High
Commissioner for Refugees UNICEF – United Nations Children’s Fund UNIDO – United Nations Industrial
Development Organization UNODC – United Nations Office on Drugs
and Crime
UNRWA – United Nations Relief and Works Agency for Palestine Refugees in the Near East
WFP – World Food Programme WIPO – World Intellectual Property
Organization
WMO – World Meteorological Organization
WTO – World Trade Organization
_______________
The designations employed and the presentation of the material in this volume do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Where the designation “country or area” appears in the headings of tables, it covers countries, territories, cities or areas.
PREFACE
The Seventieth World Health Assembly was held at the Palais des Nations, Geneva, from 22 to 31 May 2017, in accordance with the decision of the Executive Board at its 139th session.1
_______________
1 Decision EB139(11) (2016).
- iii -
CONTENTS
Page
Preface ... iii
Agenda ... ix
List of documents ... xv
Officers of the Health Assembly and membership of its committees ... xxiii
RESOLUTIONS AND DECISIONS Resolutions WHA70.1 Arrears in payment of contributions: Somalia ... 3
WHA70.2 Appointment of the Director-General ... 5
WHA70.3 Contract of the Director-General ... 5
WHA70.4 Expression of appreciation to Dr Margaret Chan ... 5
WHA70.5 Programme budget 2018–2019 ... 6
WHA70.6 Human resources for health and implementation of the outcomes of the United Nations’ High-Level Commission on Health Employment and Economic Growth... 8
WHA70.7 Improving the prevention, diagnosis and clinical management of sepsis ... 11
WHA70.8 Status of collection of assessed contributions, including Member States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution ... 14
WHA70.9 Scale of assessments for 2018–2019 ... 15
WHA70.10 Salaries of staff in ungraded posts and of the Director-General ... 20
WHA70.11 Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018 ... 20
WHA70.12 Cancer prevention and control in the context of an integrated approach ... 22
- v -
WHA70.14 Strengthening immunization to achieve the goals of the global vaccine
action plan ... 29
WHA70.15 Promoting the health of refugees and migrants ... 33
WHA70.16 Global vector control response: an integrated approach for the control of vector-borne diseases ... 34
Decisions WHA70(1) Composition of the Committee on Credentials ... 37
WHA70(2) Election of officers of the Seventieth World Health Assembly ... 37
WHA70(3) Election of officers of the main committees ... 37
WHA70(4) Establishment of the General Committee ... 38
WHA70(5) Adoption of the agenda ... 38
WHA70(6) Post of Director-General ... 38
WHA70(7) Verification of credentials ... 38
WHA70(8) Election of Members entitled to designate a person to serve on the Executive Board... 39
WHA70(9) Poliomyelitis: polio transition planning ... 39
WHA70(10) Review of the Pandemic Influenza Preparedness Framework ... 41
WHA70(11) Implementation of the International Health Regulations (2005) ... 43
WHA70(12) Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan ... 43
WHA70(13) WHO mid-term programmatic and financial report for 2016–2017, including audited financial statements for 2016 ... 44
WHA70(14) Report of the External Auditor ... 44
WHA70(15) Appointment of representatives to the WHO Staff Pension Committee ... 45
WHA70(16) Infrastructure Fund ... 45
WHA70(17) Global action plan on the public health response to dementia ... 46
WHA70(18) Public health dimension of the world drug problem ... 46
WHA70(19) Report of the Commission on Ending Childhood Obesity: implementation plan ... 47
- vi -
Tobacco Control ... 47 WHA70(21) Member State mechanism on substandard and falsified medical products ... 48 WHA70(22) Progress in the implementation of the 2030 Agenda for Sustainable
Development ... 48 WHA70(23) The role of the health sector in the Strategic Approach to International
Chemicals Management towards the 2020 goal and beyond ... 49 WHA70(24) Selection of the country in which the Seventy-first World Health Assembly
would be held ... 49
ANNEXES
1. Contract of the Director-General ... 53 2. Working for health: five-year action plan for health employment and
inclusive economic growth (2017–2021) ... 55 3. Preparation for the third High-level Meeting of the General Assembly on the
Prevention and Control of Non-communicable Diseases, to be held in 2018:
updated Appendix 3 to the global action plan for the prevention and
control of noncommunicable diseases 2013–2020 ... 71 4. Framework of priorities and guiding principles to promote the
health of refugees and migrants ... 92 5. Global vector control response 2017–2030 ... 97 6. Post of Director-General: proposals to improve the efficiency of paper-based voting
in the Health Assembly and consequent need for procedural amendments; text of amended Rules of Procedure of the World Health Assembly and of amended
Guiding Principles for the Conduct of Elections by Secret Ballot ... 104 7. Poliomyelitis: polio transition planning: list of Secretariat actions
between 1 June and 31 December 2017 ... 106 8. Report of the 2016 PIP Framework Review Group ... 108 9. Draft five-year global strategic plan to improve public health preparedness and
response 2018–2022: guiding principles ... 213 10. Global action plan on the public health response to dementia 2017–2025 ... 217 11. Implementation plan to guide further action on the recommendations included
in the Report of the Commission on Ending Childhood Obesity ... 241 12. WHO Member State mechanism on substandard and falsified medical products:
working definitions ... 266
- vii -
14. Financial and administrative implications for the Secretariat of resolutions and
decisions adopted by the Health Assembly ... 275
_______________
- viii -
AGENDA
1PLENARY
1. Opening of the Health Assembly
1.1 Appointment of the Committee on Credentials 1.2 Election of the President
1.3 Election of the five Vice-Presidents, the Chairmen of the main committees, and establishment of the General Committee
1.4 Adoption of the agenda and allocation of items to the main committees 2. Report of the Executive Board on its 139th and 140th sessions
3. Address by Dr Margaret Chan, Director-General 4. Post of Director-General
4.1 Procedures for the conduct of the election 4.2 Appointment of the Director-General 4.3 Contract of the Director-General 5. [deleted]
6. Executive Board: election 7. Awards
8. Reports of the main committees 9. Closure of the Health Assembly
1 Adopted at the second plenary meeting.
- ix -
COMMITTEE A 10. Opening of the Committee1
11. Programme and budget matters
11.1 Overview of financial situation: Programme budget 2016–2017 11.2 Proposed programme budget 2018–2019
12. Preparedness, surveillance and response 12.1 Health emergencies
• The Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme
• WHO response in severe, large-scale emergencies
• Research and development for potentially epidemic diseases
• Health workforce coordination in emergencies with health consequences 12.2 Antimicrobial resistance
12.3 Poliomyelitis
• Poliomyelitis update
• Polio transition planning
12.4 Implementation of the International Health Regulations (2005) 12.5 Review of the Pandemic Influenza Preparedness Framework 13. Health systems
13.1 Human resources for health and implementation of the outcomes of the United Nations’
High-Level Commission on Health Employment and Economic Growth
13.2 Principles on the donation and management of blood, blood components and other medical products of human origin
13.3 Addressing the global shortage of, and access to, medicines and vaccines
13.4 Evaluation and review of the global strategy and plan of action on public health, innovation and intellectual property
1 Including election of Vice-Chairmen and the Rapporteur.
- x -
13.5 Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination
13.6 Member State mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit medical products
13.7 Promoting the health of refugees and migrants 14. Communicable diseases
14.1 Global vaccine action plan 14.2 Global vector control response 15. Noncommunicable diseases
15.1 Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018
15.2 Draft global action plan on the public health response to dementia 15.3 Public health dimension of the world drug problem
15.4 Outcome of the Second International Conference on Nutrition
15.5 Report of the Commission on Ending Childhood Obesity: implementation plan 15.6 Cancer prevention and control in the context of an integrated approach
15.7 Strengthening synergies between the World Health Assembly and the Conference of the Parties to the WHO Framework Convention on Tobacco Control
15.8 Prevention of deafness and hearing loss 16. Promoting health through the life course
16.1 Progress in the implementation of the 2030 Agenda for Sustainable Development
16.2 The role of the health sector in the Strategic Approach to International Chemicals Management towards the 2020 goal and beyond
16.3 Global Strategy for Women’s, Children’s and Adolescents’ Health (2016–2030):
adolescents’ health
- xi -
17. Progress reports
Noncommunicable diseases
A. WHO global disability action plan 2014–2021: better health for all people with disability (resolution WHA67.7 (2014))
B. Addressing the challenges of the United Nations Decade of Action for Road Safety (2011–2020): outcome of the second Global High-level Conference on Road Safety – Time for Results (resolution WHA69.7 (2016))
C. Towards universal eye health: a global action plan 2014–2019 (resolution WHA66.4 (2013))
Communicable diseases
D. Eradication of dracunculiasis (resolution WHA64.16 (2011))
E. Global strategy and targets for tuberculosis prevention, care and control after 2015 (resolution WHA67.1 (2014))
F. Global technical strategy and targets for malaria 2016–2030 (resolution WHA68.2 (2015))
Promoting health through the life course
G. Public health impacts of exposure to mercury and mercury compounds: the role of WHO and ministries of public health in the implementation of the Minamata Convention (resolution WHA67.11 (2014))
H. Strategy for integrating gender analysis and actions into the work of WHO (resolution WHA60.25 (2007))
Health systems
I. Progress in the rational use of medicines (resolution WHA60.16 (2007))
J. Regulatory system strengthening for medical products (resolution WHA67.20 (2014)) K. Strengthening emergency and essential surgical care and anaesthesia as a component of
universal health coverage (resolution WHA68.15 (2015)) Preparedness, surveillance and response
L. Smallpox eradication: destruction of variola virus stocks (resolution WHA60.1 (2007)) M. Enhancement of laboratory biosafety (resolution WHA58.29 (2005))
20.3 Special arrangements for settlement of arrears
- xii -
COMMITTEE B 18. Opening of the Committee1
19. Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan
20. Financial matters
20.1 WHO mid-term programmatic and financial report for 2016–2017, including audited financial statements for 2016
20.2 Status of collection of assessed contributions, including Member States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution
20.3 [transferred to Committee A]
20.4 Scale of assessments for 2018–2019 20.5 [deleted]
20.6 [deleted]
21. Audit and oversight matters
21.1 Report of the External Auditor 21.2 Report of the Internal Auditor 22. Staffing matters
22.1 Human resources: annual report
22.2 Report of the International Civil Service Commission 22.3 Amendments to the Staff Regulations and Staff Rules 22.4 Report of the United Nations Joint Staff Pension Board
22.5 Appointment of representatives to the WHO Staff Pension Committee 23. Management, legal and governance matters
23.1 Overview of WHO reform implementation
23.2 Governance reform: follow-up to decision WHA69(8) (2016)
1 Including election of Vice-Chairmen and the Rapporteur.
- xiii -
23.3 Engagement with non-State actors
• Criteria and principles for secondments from nongovernmental organizations, philanthropic foundations and academic institutions
23.4 Proposed Infrastructure Fund (consolidating the Real Estate Fund and IT Fund) 23.5 [deleted]
24. Collaboration within the United Nations system and with other intergovernmental organizations
_______________
- xiv -
LIST OF DOCUMENTS
A70/1 Rev.2 Agenda1
A70/2 Report of the Executive Board on its 139th and 140th sessions A70/3 Address by Dr Margaret Chan, Director-General, to the Seventieth
World Health Assembly
A70/4 Post of Director-General
Note by the Legal Counsel2
A70/5 Post of Director-General
Contract of the Director-General3
A70/6 Overview of financial situation: Programme budget 2016–2017
A70/7 Proposed programme budget 2018–2019
A70/7 Add.1 Rev.1 Draft resolution: Programme budget 2018–2019
A70/8 Report of the Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme
A70/9 Health emergencies
WHO response in severe, large-scale emergencies
A70/10 Research and development for potentially epidemic diseases A70/11 Health workforce coordination in emergencies with health
consequences
A70/12 Antimicrobial resistance
A70/13 Improving the prevention, diagnosis and clinical management of sepsis
A70/14 Poliomyelitis
A70/14 Add.1 Polio transition planning4
1 See page ix.
2 See Annex 6.
3 See Annex 1.
4 See Annex 7.
- xv -
A70/15 Implementation of the International Health Regulations (2005) Annual report on the implementation of the International Health Regulations (2005)
A70/16 Implementation of the International Health Regulations (2005) Global implementation plan1
A70/17 Review of the Pandemic Influenza Preparedness Framework2 A70/18 Human resources for health and implementation of the outcomes of
the United Nations’ High-Level Commission on Health Employment and Economic Growth3
A70/19 Principles on the donation and management of blood, blood components and other medical products of human origin A70/20 Addressing the global shortage of, and access to, medicines and
vaccines
A70/21 Evaluation and review of the global strategy and plan of action on public health, innovation and intellectual property
A70/22 Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination
A70/23 Member State mechanism on substandard/spurious/falsely- labelled/falsified/counterfeit medical products4
A70/23 Add.1 Review of the Member State mechanism on
substandard/spurious/falsely-labelled/falsified/counterfeit medical products
A70/23 Add.2 Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Health Assembly5 A70/24 Promoting the health of refugees and migrants6
A70/25 Global vaccine action plan
1 See Annex 9.
2 See Annex 8.
3 See Annex 2.
4 See Annex 12.
5 See Annex 14
6 See Annex 4.
- xvi -
A70/26 Rev.1 and A70/26 Rev.1 Add.1
Global vector control response1
A70/26 Rev.1 Add.2 Financial and administrative implications for the Secretariat of resolutions proposed for adoption by the Health Assembly2
A70/27 Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 20183
A70/28 Draft global action plan on the public health response to dementia4 A70/29 Public health dimension of the world drug problem
A70/30 Outcome of the Second International Conference on Nutrition A70/31 Report of the Commission on Ending Childhood Obesity:
implementation plan5
A70/32 Cancer prevention and control in the context of an integrated approach
A70/33 Strengthening synergies between the World Health Assembly and the Conference of the Parties to the WHO Framework Convention on Tobacco Control
A70/34 Prevention of deafness and hearing loss
A70/35 Progress in the implementation of the 2030 Agenda for Sustainable Development
A70/36 The role of the health sector in the Strategic Approach to
International Chemicals Management towards the 2020 goal and beyond6
A70/36 Add.1 Financial and administrative implications for the Secretariat of decisions proposed for adoption by the Health Assembly7
1 See Annex 5.
2 See Annex 14.
3 See Annex 3.
4 See Annex 10.
5 See Annex 11.
6 See Annex 13.
7 See Annex 14.
- xvii -
A70/37 Global Strategy for Women’s, Children’s and Adolescents’ Health (2016–2030): adolescents’ health
A70/38 Progress reports
A70/39 Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan
A70/40 WHO mid-term programmatic and financial report for 2016–2017, including audited financial statements for 2016
A70/41 Status of collection of assessed contributions, including Member States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution
A70/42 Scale of assessments for 2018–2019 A70/43 Report of the External Auditor A70/44 Report of the Internal Auditor A70/45 Human resources: annual report
A70/46 Report of the International Civil Service Commission A70/47 Amendments to the Staff Regulations and Staff Rules A70/48 Report of the United Nations Joint Staff Pension Board A70/49 Appointment of representatives to the WHO Staff Pension
Committee
A70/50 Overview of WHO reform implementation A70/50 Add.1 Overview of WHO reform implementation
Leadership and management at WHO: evaluation of WHO reform, third stage
A70/50 Add.2 Overview of WHO reform implementation WHO’s performance in countries
A70/51 Governance reform: follow-up to decision WHA69(8) (2016) A70/51 Add.1 Financial and administrative implications for the Secretariat of
decisions proposed for adoption by the Health Assembly1 A70/52 Engagement with non-State actors
1 See Annex 14.
- xviii -
A70/53 Engagement with non-State actors
Criteria and principles for secondments from nongovernmental organizations, philanthropic foundations and academic institutions A70/54 Proposed Infrastructure Fund (consolidating the Real Estate Fund and
IT Fund)
A70/55 Collaboration within the United Nations system and with other intergovernmental organizations
A70/56 External and internal audit recommendations: report on implementation
A70/57 Review of the Pandemic Influenza Preparedness Framework Collaboration with the Secretariat of the Convention on Biological Diversity and other relevant international organizations
A70/58 Overview of financial situation: Programme budget 2016–2017 WHO mid-term programmatic and financial report for 2016–2017, including audited financial statements for 2016
Report of the Programme, Budget and Administration Committee of the Executive Board to the Seventieth World Health Assembly
A70/59 Proposed programme budget 2018−2019
Report of the Programme, Budget and Administration Committee of the Executive Board to the Seventieth World Health Assembly A70/60 Status of collection of assessed contributions, including Member
States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution
Report of the Programme, Budget and Administration Committee of the Executive Board to the Seventieth World Health Assembly A70/61 Report of the External Auditor
Report of the Programme, Budget and Administration Committee of the Executive Board to the Seventieth World Health Assembly A70/62 Report of the Internal Auditor
Report of the Programme, Budget and Administration Committee of the Executive Board to the Seventieth World Health Assembly A70/63 Human resources: annual report
Report of the Programme, Budget and Administration Committee of the Executive Board to the Seventieth World Health Assembly A70/64 Overview of WHO reform implementation
Report of the Programme, Budget and Administration Committee of the Executive Board to the Seventieth World Health Assembly
- xix -
A70/65 Proposed Infrastructure Fund (consolidating the Real Estate Fund and IT Fund)
Report of the Programme, Budget and Administration Committee of the Executive Board to the Seventieth World Health Assembly
A70/66 Committee on Credentials
A70/67 Special arrangements for settlement of arrears
A70/68 First report of Committee A
A70/69 Second report of Committee A
A70/70 Election of Members entitled to designate a person to serve on the Executive Board
A70/71 First report of Committee B
A70/72 Third report of Committee A
A70/73 Fourth report of Committee A
A70/74 Second report of Committee B
A70/75 Fifth report of Committee A
A70/76 Third report of Committee B
A70/77 Sixth report of Committee A
A70/78 Fourth report of Committee B Information documents
A70/INF./1 Awards
A70/INF./2 Proposed programme budget 2018–2019 Proposed increase in assessed contributions
A70/INF./3 WHO presence in countries, territories and areas: 2017 report A70/INF./4 Voluntary contributions by fund and by contributor, 2016 A70/INF./5 Financing of category 6 and cost recovery mechanisms: current
practices and proposed way forward A70/INF./6 Better value, better health
Towards a strategy and plan for value for money for WHO
- xx -
Diverse documents
A70/DIV./1 Rev.1 List of delegates and other participants
A70/DIV./2 Guide for delegates to the World Health Assembly A70/DIV./3 List of decisions and resolutions
A70/DIV./4 List of documents
_______________
- xxi -
MEMBERSHIP OF ITS COMMITTEES
President
Professor Veronika SKVORTSOVA (Russian Federation)
Vice-Presidents
Mr Nandi Tuaine GLASSIE (Cook Islands) Dr Fawziya ABIKAR NUR (Somalia) Dr Arlindo NASCIMENTO DO ROSARIO
(Cabo Verde)
Mr Patrick PENGEL (Suriname) Mr CHOE Myong Nam (Democratic
People’s Republic of Korea) Secretary
Dr Margaret CHAN, Director-General Committee on Credentials
The Committee on Credentials was composed of delegates of the following Member States: Angola; Belarus; Italy; Japan;
Lithuania; Mali; Myanmar; Panama; Paraguay;
South Sudan; Yemen.
Chairman: Mr Hiroyuki YAMAYA (Japan) Vice-Chairman: Mr Augusto Rosa NETO
(Angola)
Secretary: Mr Xavier DANEY, Senior Legal Officer
General Committee
The General Committee was composed of the President and Vice-Presidents of the Health Assembly and the chairmen of the main committees, together with the delegates of the following Member States: China, Cuba, Djibouti, Dominican Republic, France, Guinea, Kyrgyzstan, Malawi, Maldives, Malta, Mozambique, Norway, Philippines, Rwanda,
Togo, United Kingdom of Great Britain and Northern Ireland, and United States of America.
Chairman: Professor Veronika
SKVORTSOVA (Russian Federation) Secretary: Dr Margaret CHAN,
Director-General
MAIN COMMITTEES
Under Rule 33 of the Rules of Procedure of the World Health Assembly, each delegation is entitled to be represented on each main committee by one of its members.
Committee A Chairman: Dr Hanan Mohamed
AL-KUWARI (Qatar)
Vice-Chairmen: Dr Mohammad Anwar HUSNOO (Mauritius)1 and Mr Philip DAVIES (Fiji)
Rapporteur: Mr Ioannis BASKOZOS (Greece)
Secretary: Mr Ian ROBERTS, Coordinator, Library and Information Networks for Knowledge
Committee B
Chairman: Dr Molwyn JOSEPH (Antigua and Barbuda)
Vice-Chairmen: Mr Mario MIKLOSI (Slovakia) and Dr SLAMET (Indonesia) Rapporteur: Dr NGUYEN MANH CUONG
(Viet Nam)
Secretary: Dr Clive ONDARI, Coordinator, Safety and Vigilence
REPRESENTATIVE OF THE EXECUTIVE BOARD
Dr Raymond BUSUTTIL (Malta) –––––––––––––––
1 Replaced by Mr Anandrao Hurree (Mauritius) at the opening of the third meeting of Committee A.
- xxiii -
RESOLUTIONS
WHA70.1 Arrears in payment of contributions: Somalia The Seventieth World Health Assembly,
Having considered the request of Somalia (see Annex to the present resolution) in respect of its outstanding contributions of US$ 451 014, and noting payment of US$ 4650 in respect of 2016, and the commitment given to make a further payment of US$ 4650 in respect of 2017;
Having also considered the request of Somalia to reschedule payment of this balance of US$ 446 364 over the period 2018−2037;
Noting also that this request did not comply fully with the requirements of resolution WHA54.6 (2001) as to timing and procedure,
1. DECIDES to restore Somalia’s voting privileges at the Seventieth World Health Assembly on the following conditions:
Somalia shall pay its outstanding arrears of assessed contributions, totalling US$ 446 364 over 20 years from 2018 to 2037 as set out below, in addition to making payment of its annual assessment for the current year;
Year US$
2018 22 318
2019 22 318
2020 22 318
2021 22 318
2022 22 318
2023 22 318
2024 22 318
2025 22 318
2026 22 318
2027 22 318
2028 22 318
2029 22 318
2030 22 318
2031 22 318
2032 22 318
2033 22 318
2034 22 318
2035 22 318
2036 22 318
2037 22 322
TOTAL 446 364
- 3 -
2. FURTHER DECIDES that, in accordance with Article 7 of the Constitution, Somalia’s voting privileges shall be automatically suspended if it does not meet the requirements laid down in paragraph 1 above;
3. REQUESTS the Director-General to report to the Seventy-first World Health Assembly on the prevailing situation;
4. FURTHER REQUESTS the Director-General to communicate this resolution to the Government of Somalia.
ANNEX
(Fourth plenary meeting, 23 May 2017 – Committee A, first report)
WHA70.2 Appointment of the Director-General The Seventieth World Health Assembly,
On the nomination of the Executive Board,
APPOINTS Dr Tedros Adhanom Ghebreyesus as Director-General of the World Health Organization.
(Fifth plenary meeting, 23 May 2017) WHA70.3 Contract of the Director-General
The Seventieth World Health Assembly, I
Pursuant to Article 31 of the Constitution and Rule 107 of the Rules of Procedure of the World Health Assembly,
APPROVES the contract establishing the terms and conditions of appointment, salary and other emoluments for the post of Director-General, as amended;1
II
Pursuant to Rule 110 of the Rules of Procedure of the World Health Assembly,
AUTHORIZES the President of the Seventieth World Health Assembly to sign this contract in the name of the Organization.
(Fifth plenary meeting, 23 May 2017) WHA70.4 Expression of appreciation to Dr Margaret Chan
The Seventieth World Health Assembly,
Expressing its profound gratitude to Dr Margaret Chan for her extraordinary leadership of the World Health Organization during the period 2007−2017;
Commending her dedication to partnership and evidence-based approaches to public health, and her drive towards organizational effectiveness, and transparency and accountability;
Paying tribute to her unwavering efforts and skilful stewardship to ensure the prominence of health on national and global political agendas;
Recognizing her resilience in overcoming unprecedented global public health challenges encountered during the course of her tenure;
1 See Annex 1.
Acclaiming her tireless commitment to improve the health of all peoples around the world, DECLARES Dr Margaret Chan Director-General Emeritus of the World Health Organization as from the date of her retirement.
(Fifth plenary meeting, 23 May 2017) WHA70.5 Programme budget 2018–2019
The Seventieth World Health Assembly,
Having considered the Proposed programme budget 2018–2019;1
Having noted the report of the Programme, Budget and Administration Committee of the Executive Board to the Seventieth World Health Assembly;2
Welcoming the work being conducted to identify efficiencies in the area of management and administration;
Considering the continuing increase in the volume of tasks assigned by WHO’s governing bodies to the Director-General, including the recent creation of the WHO Health Emergencies Programme;
Conscious of the necessity to prioritize and, in a context of limited resources, to concentrate such resources on those programmes that have the greatest impact on public health, or where WHO has a significant comparative advantage, as agreed by the Member States;
Stressing that proposed increases above the level of the approved Programme budget 2018−2019 should be requested only when necessary for the purpose of the Organization’s mandated activities and after all possible steps have been taken to finance such increases through savings, efficiencies and prioritization,
1. APPROVES the programme of work, as outlined in the Proposed programme budget 2018–2019;
2. APPROVES the budget for the financial period 2018–2019, under all sources of funds, namely, assessed and voluntary contributions of US$ 4421.5 million;
3. ALLOCATES the budget for the financial period 2018–2019 to the following categories and other areas:
(1) Communicable diseases US$ 805.4 million;
(2) Noncommunicable diseases US$ 351.4 million;
(3) Promoting health through the life course US$ 384.3 million;
1 Document A70/7.
2 Document A70/59.
(4) Health systems US$ 589.5 million;
(E) WHO Health Emergencies Programme US$ 554.2 million;
(6) Corporate services/enabling functions US$ 715.5 million;
Other areas:
• Polio eradication (US$ 902.8 million), Tropical disease research (US$ 50.0 million), and Research in human reproduction (US$ 68.4 million) totalling US$ 1021.2 million;
and
• Outbreak and crisis response and scalable operations, which is subject to the event- driven nature of the activities concerned and, as such, does not have a budget requirement;
4. RESOLVES that the budget will be financed as follows:
• by net assessments on Member States adjusted for estimated Member State non-assessed income, for a total of US$ 956.9 million;
• from voluntary contributions, for a total of US$ 3464.6 million;
5. FURTHER RESOLVES that the gross amount of the assessed contribution for each Member State shall be reduced by the sum standing to their credit in the Tax Equalization Fund; that this reduction shall be adjusted in the case of those Members that require staff members to pay income taxes on their WHO emoluments, taxes which the Organization reimburses to said staff members; and that the amount of such tax reimbursements is estimated at US$ 31.8 million, resulting in a total assessment on Members of US$ 988.7 million;
6. DECIDES that the Working Capital Fund shall be maintained at its existing level of US$ 31 million;
7. AUTHORIZES the Director-General to use the assessed contributions together with the voluntary contributions, subject to the availability of resources, to finance the budget as allocated in paragraph 3, up to the amounts approved;
8. FURTHER AUTHORIZES the Director-General, where necessary, to make budget transfers among the six categories, up to an amount not exceeding 5% of the amount allocated to the category from which the transfer is made. Any such transfers will be reported in the statutory reports to the respective governing bodies;
9. FURTHER AUTHORIZES the Director-General, where necessary, to incur expenditures in the Outbreak and crisis response and scalable operations area, subject to availability of resources;
10. FURTHER AUTHORIZES the Director-General, where necessary, to incur expenditures in the Polio, Tropical disease research, and Research in human reproduction components of the budget beyond the amount allocated for those components, as a result of additional governance and resource mobilization mechanisms, as well as their budget cycle, which inform the annual/biennial budgets for these special programmes, subject to availability of resources;
11. REQUESTS the Director-General:
(1) to submit regular reports on the financing and implementation of the budget as presented in document A70/7 and on the outcome of the financing dialogue, the strategic allocation of flexible resources and the results of the coordinated resource mobilization strategy, through the Executive Board and its Programme, Budget and Administration Committee, to the World Health Assembly;
(2) to submit regular reports on the availability of resources and expenditures under the budget areas of Outbreak and crisis response and scalable operations, and Polio, together with the special programmes of the Tropical disease research, and Research on human reproduction areas;
(3) to provide additional information on the prioritization process and a plan, including details of the activities that should be discontinued, in preparation for the Thirteenth General Programme of Work, through the Executive Board and its Programme Budget and Administration Committee, to the Seventy-first World Health Assembly;
(4) to control costs and seek efficiencies, and to submit regular reports with detailed information on savings and efficiencies as well as an estimation of savings achieved.
(Eighth plenary meeting, 26 May 2017 – Committee A, second report) WHA70.6 Human resources for health and implementation of the outcomes of the United Nations’ High-Level Commission on Health Employment and Economic Growth1
The Seventieth World Health Assembly,
Having considered the report on human resources for health and implementation of the outcomes of the United Nations’ High-Level Commission on Health Employment and Economic Growth;2
Reaffirming resolution WHA69.19 (2016) on the global strategy on human resources for health:
workforce 2030, in which the Health Assembly adopted WHO’s Global Strategy on Human Resources for Health: Workforce 2030, including its strong call to engage across public and private sectors and stakeholders including government, education and training institutions, employers and health workers’
organizations in order to coordinate an intersectoral health and social workforce agenda towards achieving a fit-for-purpose workforce for the 2030 Agenda;
Recalling resolution WHA63.16 (2010) on the WHO Global Code of Practice on the International Recruitment of Health Personnel, which adopted the Global Code, and the Global Code’s recognition that an adequate and accessible health workforce is fundamental to an integrated and effective health system, and to the provision of health services, bearing in mind the necessity of mitigating the negative effects of health personnel migration on the health systems of developing countries;
1 See Annex 14 for the financial and administrative implications for the Secretariat of this resolution.
2 Document A70/18.
Recalling also previous Health Assembly resolutions aimed at strengthening the health workforce;1
Further recalling the United Nations General Assembly resolutions in 2015 (resolution 70/183) and 2016 (resolution 71/159) that, respectively, requested the establishment of the United Nations’
High-Level Commission on Health Employment and Economic Growth (hereinafter “the Commission”) and welcomed the Commission’s report;
Underlining that investing in the health and social workforce has multiplier effects that enhance inclusive economic growth, both locally and globally, and that it contributes to the ambition of the 2030 Agenda for Sustainable Development and to progress towards achieving the Sustainable Development Goals, including Goal 1 (End poverty in all its forms everywhere), Goal 3 (Ensure healthy lives and promote well-being for all at all ages), Goal 4 (Ensure inclusive and equitable quality education and promote lifelong learning opportunities for all), Goal 5 (Achieve gender equality and empower all women and girls), Goal 8 (promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all), and Goal 10 (Reduce inequality within and among countries) and exploiting the interlinkages between the Goals and their targets;
Acknowledging that twenty-first century health challenges related to demographic, socioeconomic, environmental, epidemiological and technological changes will require a health and social workforce that is fit for purpose for the provision of integrated people-centred health and social services across the continuum of care;
Recalling decision EB140(3) (2017) which, inter alia, welcomed the report of the High-Level Commission on Health Employment and Economic Growth, and its task of lending the necessary political, intersectoral and multistakeholder momentum, through the elaboration of 10 recommendations and the identification of five immediate actions, in order to guide and stimulate the creation of health and social sector jobs as a means to advance inclusive economic growth and social cohesion;
Underscoring that skilled and motivated health and social sector workers are integral to building strong and resilient health systems, and underlining the importance of adequate workforce investments to meet needs in respect of universal health coverage and to develop core capacities under the International Health Regulations (2005), including the capacity of the domestic health workforce to ensure preparedness for and response to public health threats;
Recognizing the need to substantially expand and transform health financing and the recruitment, development, education and training, distribution and retention of the health and social workforce;
Recognizing also the need to substantially increase the protection and security of health and social workers and health facilities in all settings, including acute and protracted public health emergencies and humanitarian settings,
1 Resolutions WHA64.6 (2011) on health workforce strengthening, WHA64.7 (2011) on strengthening nursing and midwifery, WHA65.20 (2012) on WHO’s response, and role as the health cluster lead, in meeting the growing demands of health in humanitarian emergencies, WHA66.23 (2013) on transforming health workforce education in support of universal health coverage, WHA67.19 (2014) on strengthening of palliative care as a component of comprehensive care throughout the life course, WHA67.24 (2014) on follow-up of the Recife Political Declaration on Human Resources for Health: renewed commitments towards universal health coverage, and WHA68.15 (2015) on strengthening emergency and essential surgical care and anaesthesia as a component of universal health coverage.
1. ADOPTS “Working for Health”: the ILO, OECD and WHO five-year action plan for health employment and inclusive economic growth (2017–2021)1 as a mechanism for coordinating and advancing the intersectoral implementation of the Commission’s recommendations and immediate actions in support of WHO’s Global Strategy on Human Resources for Health: Workforce 2030;
2. URGES all Member States to act forthwith on the Commission’s recommendations and immediate actions, with the support of WHO, ILO and OECD,2 as appropriate and consistent with national contexts, priorities and specificities;
3. INVITES international, regional, national and local partners and stakeholders responsible for health, social and gender matters, and for foreign affairs, education, finance and labour, to engage in and support the implementation of the Commission’s recommendations and the five-year action plan for health employment and inclusive economic growth (2017–2021) as a whole;
4. REQUESTS the Director-General:
(1) to collaborate with Member States, upon request, with agencies in other relevant sectors, and with partners, in implementing the Commission’s recommendations and immediate actions as elaborated in the five-year action plan for health employment and inclusive economic growth (2017–2021), including to:
(a) strengthen the progressive development and implementation of national health workforce accounts;
(b) strengthen the relevance, effectiveness and implementation of the WHO Global Code of Practice on the International Recruitment of Health Personnel, including by continuously fostering bilateral and multilateral dialogue and cooperation to promote mutuality of benefits deriving from the international mobility of health workers;
(c) catalyse the scale-up and transformation of professional, technical and vocational education and training, including inter-professional education, particularly in community- and health systems-based settings, and stimulate investments in creating decent health and social jobs with the right skills, in the right numbers and in the right places, particularly in countries facing the greatest challenges in attaining universal health coverage and in implementing the Global Strategy on Human Resources for Health:
Workforce 2030;
(2) to coordinate and work with ILO, OECD and other relevant sectors, agencies and partners to develop their joint capacity to support Member States, upon request, in this agenda, including with respect to:
(a) the establishment of an inter-agency data exchange and online knowledge platform on the health and social workforce, respecting personal confidentiality and relevant data protection laws, that progressively brings together data and information from multiple agencies, sectors and sources to advance health and social labour market data, analysis, accountability, monitoring and tracking, as an open-access, electronic, and real-time web-based resource, building on the progressive implementation and reporting of national health workforce accounts; and
1 See Annex 2.
2 And, where applicable, regional economic integration organizations.
(b) the establishment of an international platform on health worker mobility for transparent intersectoral policy dialogue, exchange and collective action in order to achieve a sustainable health and social workforce, maximize mutual benefits, promote ethical recruitment and mitigate adverse effects arising from such mobility;
(3) to utilize the Global Health Workforce Network as a mechanism to engage stakeholders in the implementation of the five-year action plan for health employment and inclusive economic growth (2017–2021);
(4) to explore intersectoral and innovative financing mechanisms necessary for advancing implementation of the five-year action plan for health employment and inclusive economic growth (2017–2021);
(5) to accelerate progress in health workforce monitoring with the application of national health workforce accounts, and ensure the appropriate number, competency and equitable distribution of health workers;
(6) to submit a regular report to the Health Assembly on progress made in implementing the five-year action plan for health employment and inclusive economic growth (2017–2021), aligned with reporting on the Global Strategy on Human Resources for Health:
Workforce 2030.
(Ninth plenary meeting, 29 May 2017 – Committee A, third report) WHA70.7 Improving the prevention, diagnosis and clinical management of sepsis1
The Seventieth World Health Assembly,
Having considered the report on improving the prevention, diagnosis and clinical management of sepsis;2
Concerned that sepsis continues to cause approximately six million deaths worldwide every year, most of which are preventable;
Recognizing that sepsis as a syndromic response to infection is the final common pathway to death from most infectious diseases worldwide;
Considering that sepsis follows a unique and time-critical clinical course, which in the early stages is highly amenable to treatment through early diagnosis and timely and appropriate clinical management;
Considering also that infections that may lead to sepsis can often be prevented through appropriate hand hygiene, access to vaccination programmes, improved sanitation and water quality and availability, and other infection prevention and control best practices; and that forms of septicaemia associated with nosocomial infections are severe, hard to control and have high fatality rates;
1 See Annex 14 for the financial and administrative implications for the Secretariat of this resolution.
2 Document A70/13.
Recognizing that while sepsis itself cannot always be predicted, its ill effects in terms of mortality and long-term morbidity can be mitigated through early diagnosis and appropriate and timely clinical management;
Recognizing also the need to improve measures for the prevention of infections and control of the consequences of sepsis due to inadequate infection prevention and control programmes, insufficient health education and recognition in respect of early sepsis, inadequate access to affordable, timely and appropriate treatment and care, and insufficient laboratory services, as well as the lack of integrated approaches to the prevention and clinical management of sepsis;
Noting that health care-associated infections represent a common pathway through which sepsis can place an increased burden on health care resources;
Considering the need for an integrated approach to tackling sepsis that focuses on prevention, early recognition through clinical and laboratory services, and timely access to health care, including intensive care services, with reliability in the delivery of the basics of care, including intravenous fluids and the timely administration of antimicrobials, where indicated;
Acknowledging that: (i) the inappropriate and excessive use of antimicrobials contributes to the threat of antimicrobial resistance; (ii) the global action plan on antimicrobial resistance adopted in resolution WHA68.7 (2015),1 as well as resolution WHA67.25 (2014), urged WHO to accelerate efforts to secure access to effective antimicrobials and to use them responsibly and prudently;
(iii) sepsis represents the most vital indication for the responsible use of effective antimicrobials for human health; (iv) in the absence of appropriate and timely clinical management, including effective antimicrobials, sepsis would be almost universally fatal; (v) ineffective or incomplete antimicrobial therapy for infections, including sepsis, may be a major contributor to the increasing threat of antimicrobial resistance; (vi) the incidence of some resistant pathogens may be reduced by the use of appropriate vaccines; and (vii) immunocompromised patients are most at risk from very serious forms of septicaemia;
Recognizing that many vaccine-preventable diseases are major contributors to sepsis, and reaffirming resolution WHA45.17 (1992) on immunization and vaccine quality, which urged Member States, inter alia, to integrate cost-effective and affordable new vaccines into national immunization programmes in countries where this is feasible;
Recognizing also the importance of strong, functional health systems, which include organizational and therapeutic strategies in order to improve patient safety and outcomes from sepsis of bacterial origin;
Further recognizing the need to prevent and control sepsis, to increase timely access to correct diagnosis and to provide appropriate treatment programmes;
Also recognizing the advocacy efforts of stakeholders, in particular through existing activities held every year on 13 September2 in many countries, to raise awareness regarding sepsis,
1 See document WHA68/2015/REC/1, Annex 3.
2 See document A70/13, paragraph 11: civil society organizations promote a World Sepsis Day on 13 September.
1. URGES Member States:1
(1) to include prevention, diagnosis and treatment of sepsis in national health systems strengthening in the community and in health care settings, according to WHO guidelines;
(2) to reinforce existing strategies or develop new ones leading to strengthened infection prevention and control programmes, including by strengthening hygienic infrastructure, promoting hand hygiene, and other infection prevention and control best practices, clean childbirth practices, infection prevention practices in surgery, improvements in sanitation, nutrition and delivery of clean water, access to vaccination programmes, provision of effective personal protective equipment for health professionals and infection control in health care settings;
(3) to continue in their efforts to reduce antimicrobial resistance and promote the appropriate use of antimicrobials in accordance with the global action plan on antimicrobial resistance,2 including the development and implementation of comprehensive antimicrobial stewardship activities;
(4) to develop and implement standard and optimal care and strengthen medical countermeasures for diagnosing and managing sepsis in health emergencies, including outbreaks, through appropriate guidelines with a multisectoral approach;
(5) to increase public awareness of the risk of progression to sepsis from infectious diseases, through health education, including on patient safety, in order to ensure prompt initial contact between affected persons and the health care system;
(6) to develop training for all health professionals on infection prevention and patient safety, and on the importance of recognizing sepsis as a preventable and time-critical condition with urgent therapeutic need, and of communicating with patients, relatives and other parties using the term “sepsis” in order to enhance public awareness;
(7) to promote research aimed at innovative means of diagnosing and treating sepsis across the lifespan, including research for new antimicrobial and alternative medicines, rapid diagnostic tests, vaccines and other important technologies, interventions and therapies;
(8) to apply and improve the use of the International Classification of Diseases system to establish the prevalence and profile of sepsis and antimicrobial resistance, and to develop and implement monitoring and evaluation tools in order to focus attention on and monitor progress towards improving outcomes from sepsis, including the development and fostering of specific epidemiologic surveillance systems, and to guide evidence-based strategies for policy decisions related to preventive, diagnostic and treatment activities and access to relevant health care for survivors;
(9) to engage further in advocacy efforts to raise awareness of sepsis, in particular through supporting existing activities held every year on 13 September in Member States;3
1 And, where applicable, regional economic integration organizations.
2 See document WHA68/2015/REC/1, Annex 3.
3 See document A70/13, paragraph 11: civil society organizations promote a World Sepsis Day on 13 September.
2. REQUESTS the Director-General:
(1) to develop WHO guidance including guidelines, as appropriate, on sepsis prevention and management;
(2) to draw attention to the public health impact of sepsis, including by publishing a report on sepsis describing its global epidemiology and impact on the burden of disease, and identifying successful approaches for integrating the timely diagnosis and management of sepsis into existing health systems, by the end of 2018;
(3) to support Member States, as appropriate, to define standards and establish the necessary guidelines, infrastructures, laboratory capacity, strategies and tools for reducing the incidence of, mortality from and long-term complications of sepsis;
(4) to collaborate with other organizations in the United Nations system, partners, international organizations and other relevant stakeholders in enhancing access to quality, safe, efficacious and affordable types of treatments for sepsis, and infection prevention and control, including immunization, particularly in developing countries, while taking into account relevant existing initiatives;
(5) to report to the Seventy-third World Health Assembly on the implementation of this resolution.
(Ninth plenary meeting, 29 May 2017 – Committee A, fourth report) WHA70.8 Status of collection of assessed contributions, including Member States
in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution
The Seventieth World Health Assembly,
Having considered the report on the status of collection of assessed contributions, including Member States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution, and special arrangements for settlement of arrears;1
Having noted the report of the Programme, Budget and Administration Committee of the Executive Board to the Seventieth World Health Assembly;2
Noting that, at the time of opening of the Seventieth World Health Assembly, the voting rights of Central African Republic, Comoros, Guinea-Bissau, Somalia and Ukraine were suspended, and that such suspension shall continue until the arrears of the Member States concerned have been reduced, at the present or future Health Assemblies, to a level below the amount that would justify invoking Article 7 of the Constitution;
1 Document A70/41.
2 Document A70/60.
Noting that Equatorial Guinea, Gambia, Grenada, and South Sudan were in arrears at the time of the opening of the Seventieth World Health Assembly to such an extent that it was necessary for the Health Assembly to consider, in accordance with Article 7 of the Constitution, whether the voting privileges of those countries should be suspended at the opening of the Seventy-first World Health Assembly,
DECIDES:
(1) that, in accordance with the statement of principles set out in resolution WHA41.7 (1988), if, by the time of the opening of the Seventy-first World Health Assembly, Equatorial Guinea, Gambia, Grenada, and South Sudan are still in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution, their voting privileges shall be suspended as from the said opening;
(2) that any suspension that takes effect as set out in paragraph (1) above shall continue at the Seventy-first World Health Assembly and subsequent Health Assemblies, until the arrears of Equatorial Guinea, Gambia, Grenada, and South Sudan have been reduced to a level below the amount that would justify invoking Article 7 of the Constitution;
(3) that this decision shall be without prejudice to the right of any Member to request restoration of its voting privileges in accordance with Article 7 of the Constitution.
(Ninth plenary meeting, 29 May 2017 – Committee B, first report) WHA70.9 Scale of assessments for 2018–2019
The Seventieth World Health Assembly,
Having considered the report of the Director-General,1
ADOPTS the scale of assessments of Members and Associate Members for the biennium 2018–2019 as set out below.
Members and Associate Members
WHO scale for 2018–2019
%
Afghanistan 0.0060
Albania 0.0080
Algeria 0.1610
Andorra 0.0060
Angola 0.0100
Antigua and Barbuda 0.0020
Argentina 0.8920
Armenia 0.0060
Australia 2.3371
Austria 0.7201
Azerbaijan 0.0600
1 Document A70/42.
Members and Associate Members
WHO scale for 2018–2019
%
Bahamas 0.0140
Bahrain 0.0440
Bangladesh 0.0100
Barbados 0.0070
Belarus 0.0560
Belgium 0.8851
Belize 0.0010
Benin 0.0030
Bhutan 0.0010
Bolivia (Plurinational State of) 0.0120
Bosnia and Herzegovina 0.0130
Botswana 0.0140
Brazil 3.8232
Brunei Darussalam 0.0290
Bulgaria 0.0450
Burkina Faso 0.0040
Burundi 0.0010
Cabo Verde 0.0010
Cambodia 0.0040
Cameroon 0.0100
Canada 2.9211
Central African Republic 0.0010
Chad 0.0050
Chile 0.3990
China 7.9212
Colombia 0.3220
Comoros 0.0010
Congo 0.0060
Cook Islands 0.0010
Costa Rica 0.0470
Côte d’Ivoire 0.0090
Croatia 0.0990
Cuba 0.0650
Cyprus 0.0430
Czechia 0.3440
Democratic People’s Republic of
Korea 0.0050
Democratic Republic of the Congo 0.0080
Denmark 0.5840
Djibouti 0.0010
Dominica 0.0010
Dominican Republic 0.0460
Ecuador 0.0670
Egypt 0.1520
El Salvador 0.0140
Equatorial Guinea 0.0100
Members and Associate Members
WHO scale for 2018–2019
%
Eritrea 0.0010
Estonia 0.0380
Ethiopia 0.0100
Fiji 0.0030
Finland 0.4560
France 4.8592
Gabon 0.0170
Gambia 0.0010
Georgia 0.0080
Germany 6.3892
Ghana 0.0160
Greece 0.4710
Grenada 0.0010
Guatemala 0.0280
Guinea 0.0020
Guinea-Bissau 0.0010
Guyana 0.0020
Haiti 0.0030
Honduras 0.0080
Hungary 0.1610
Iceland 0.0230
India 0.7370
Indonesia 0.5040
Iran (Islamic Republic of) 0.4710
Iraq 0.1290
Ireland 0.3350
Israel 0.4300
Italy 3.7482
Jamaica 0.0090
Japan 9.6802
Jordan 0.0200
Kazakhstan 0.1910
Kenya 0.0180
Kiribati 0.0010
Kuwait 0.2850
Kyrgyzstan 0.0020
Lao People’s Democratic Republic 0.0030
Latvia 0.0500
Lebanon 0.0460
Lesotho 0.0010
Liberia 0.0010
Libya 0.1250
Lithuania 0.0720
Luxembourg 0.0640
Madagascar 0.0030
Members and Associate Members
WHO scale for 2018–2019
%
Malawi 0.0020
Malaysia 0.3220
Maldives 0.0020
Mali 0.0030
Malta 0.0160
Marshall Islands 0.0010
Mauritania 0.0020
Mauritius 0.0120
Mexico 1.4351
Micronesia (Federated States of) 0.0010
Monaco 0.0100
Mongolia 0.0050
Montenegro 0.0040
Morocco 0.0540
Mozambique 0.0040
Myanmar 0.0100
Namibia 0.0100
Nauru 0.0010
Nepal 0.0060
Netherlands 1.4821
New Zealand 0.2680
Nicaragua 0.0040
Niger 0.0020
Nigeria 0.2090
Niue 0.0010
Norway 0.8491
Oman 0.1130
Pakistan 0.0930
Palau 0.0010
Panama 0.0340
Papua New Guinea 0.0040
Paraguay 0.0140
Peru 0.1360
Philippines 0.1650
Poland 0.8411
Portugal 0.3920
Puerto Rico 0.0010
Qatar 0.2690
Republic of Korea 2.0391
Republic of Moldova 0.0040
Romania 0.1840
Russian Federation 3.0882
Rwanda 0.0020
Saint Kitts and Nevis 0.0010
Saint Lucia 0.0010
Saint Vincent and the Grenadines 0.0010
Samoa 0.0010